US Xeljanz approval

November 9, 2012

THE US Food and Drug Administration has approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant of, methotrexate. The safety and effectiveness of Xeljanz was evaluated in seven clinical trials in adult patients with moderately to severely active rheumatoid arthritis. In all of the trials, patients treated with Xeljanz experienced improvement in clinical response and physical functioning compared to patients treated with placebo. The drug will however carry a warning on its box about its association with an increased risk of serious infections, including opportunistic infections.

The above article was sent to subscribers in Pharmacy Daily's issue from 09 Nov 12
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Nov 12

Other recent headlines

Peters wins top fellowship
Tuesday | Apr 16 2024

THE 2024 Asthma and Airways Career Development Fellowship was awarded yesterday to food allergy researcher A/Prof Rachel Peters (pictured).

Botanix listed on All Ords
Tuesday | Apr 16 2024

DERMATOLOGY company Botanix Pharmaceuticals Limited has been officially included yesterday in the Australian Securities Exchange (ASX) All Ordinaries Index (All Ords).

3D films target tumours
Tuesday | Apr 16 2024

RESEARCHERS at the University of South Australia have developed a new method for treating liver cancer, using 3D printed films that deliver chemotherapy drugs directly to the site of the tumour.

SEARCH PHARMACY DAILY

Featured video
MORE VIDEOS

Recent issues

PD for Tue 16 Apr 2024
PD for Mon 15 Apr 2024
PD for Fri 12 Apr 2024
PD for Thu 11 Apr 2024
PD for Wed 10 Apr 2024
SEE MORE ISSUES

INDUSTRY JOB VACANCIES

Pharmacist in Charge – SA
Pharmacist Manager – WA
Compounding Pharmacist – Melbourne
Pharmacist in Charge – QLD North
Pharmacist – Sydney North
SEE MORE JOBS

Pharmacy Daily is Australia's favourite online publication dedicated to the pharmacy industry. The publication launched in March 2007 and is distributed every day by email to pharmacists across the country.

PHARMACY DAILY NEWS
Headlines

Jobs

New Products

Events Calendar

FEEDS
News Items RSS feed

PD Issues RSS feed

All content RSS feed

Content & Media
Pharmacy Daily TV

OUR SITES
Sitemap

Travel Daily

Travel Bulletin

Cruise Weekly

Business Events News

Pharmacy Daily

ADVERTISE WITH US
Advertise in Pharmacy Daily

Privacy

ADMIN
Log in

SUBSCRIBE
Sign up for FREE

Subscription Information

"Water, air, and cleanness are the chief articles in my pharmacy." - Napoleon Bonaparte

Copyright © 2018 Pharmacy Daily

Subscribe to Pharmacy Daily now!

FREE Pharmacy Daily subscription - never miss another story!

Name*
First Last
Email*

Profession
Company

Address
City State / Province / Region ZIP / Postal Code Country

By submitting this form I hereby certify that I understand that Pharmacy Daily is a publication for health professionals.
Email
This field is for validation purposes and should be left unchanged.

to top

Pharmacy Daily | US Xeljanz approval

US Xeljanz approval

Other recent headlines

Peters wins top fellowship

Botanix listed on All Ords

3D films target tumours

SEARCH PHARMACY DAILY

Featured video

Recent issues

INDUSTRY JOB VACANCIES